$KIDS

ORTHOPEDIATRICS CORP

0
1
0

No SEC Form 4 filings for $KIDS in the last 30 days.

See all $KIDS insider activity →

OrthoPediatrics Corp. (KIDS) Launches Pediatric Knee Contracture Brace

OrthoPediatrics Corp. (KIDS) introduced the OPSB Knee 'TractorFIX,' a pediatric knee contracture management orthosis. The device connects to its ORTHEX External Fixation platform, aligning with KIDS' strategy to expand pediatric orthopedic solutions. Investors should monitor adoption, revenue impact, and surgeon uptake for further insights.

Squadron Capital LLC sold $6.4M of KIDS

Squadron Capital LLC sold 302,369 shares of ORTHOPEDIATRICS CORP (KIDS) at $21.01 ($6.35M total) on 2026-09-10. Filed jointly with Squadron Capital Holdings LLC (10% owner).

KIDS sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning KIDS (ORTHOPEDIATRICS CORP). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent KIDS coverage spans insider activity, earnings and financial news.

What's driving KIDS

AlphAI scores every news story that mentions KIDS with an AI model for sentiment and relevance, and aggregates insider trades from ORTHOPEDIATRICS CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KIDS

Score

OrthoPediatrics Corp. (KIDS) Launches Pediatric Knee Contracture Brace

OrthoPediatrics Corp. (KIDS) introduced the OPSB Knee 'TractorFIX,' a pediatric knee contracture management orthosis. The device connects to its ORTHEX External Fixation platform, aligning with KIDS' strategy to expand pediatric orthopedic solutions. Investors should monitor adoption, revenue impact, and surgeon uptake for further insights.

$KIDSHighAI 8/10

OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher

OrthoPediatrics (KIDS) reported Q2 revenue of $70.5M, up 15% YoY, and raised 2026 guidance to $265M-$269M. Trauma and Deformity revenue grew 26%, while international sales rose 22%. Despite higher expenses, gross margin expanded to 74% and adjusted EBITDA doubled to $6.8M. Net loss remained at $7.2M, and cash reserves declined to $47.9M.

Tuesday’s insider buys and sells: Quoin Pharma executives lead purchases

Quoin Pharmaceuticals (QNRX) executives bought shares at $4.88 each, now at $6.51. CuriosityStream (CURI) CEO bought shares near 52-week low. FTC Solar (FTCI) director increased stake. Motorsport Games (MSGM) saw insider buying. Airbnb (ABNB) strategy officer sold $13.45M in shares. ORTHOPEDIATRICS (KIDS) saw major share sales. Oruka Therapeutics (ORKA) CEO sold $6.89M in shares. Aura Minerals (AUGO) director had net buying. Caterpillar (CAT) CEO sold $26.21M in shares.

Related tickers